Back to User profile » Dr Juan Tong
Papers published by Dr Juan Tong:
Superior Efficacy and Deep Molecular Remission with Venetoclax Plus Hypomethylating Agent in Elderly Acute Myeloid Leukemia: A Real-World Comparative Cohort Study
Luo C, Jiang Y, Yan H, Sun K, Li W, Cao M, Zhu L, Hu X, Tong J, Zheng C
Clinical Pharmacology: Advances and Applications 2026, 18:596901
Published Date: 3 May 2026
Venetoclax Plus Hypomethylating Agents for Treatment-Naïve Myelodysplastic Syndromes with Increased Blasts: A Prospective Multicenter Cohort Study
Zhao N, Zhu L, Hu X, Tong J, Ge H, Ye L, Zhu X, Gai C, Feng Y, Zhang L, Wang L, Sun G, Xue L, Zhu X, Zheng C
Blood and Lymphatic Cancer: Targets and Therapy 2026, 16:592550
Published Date: 24 April 2026
Development and Validation of a Novel Thrombosis Prediction Model for Adult Immune Thrombocytopenia (ITP-THROMBO)
Yan H, Hu X, Zhu L, Jiang Y, Luo C, Lv M, Wang Y, Tong J, Zheng C
Journal of Blood Medicine 2026, 17:570135
Published Date: 21 January 2026
Real-World Analysis of Clinical Characteristics, Treatment Outcomes, and the Novel Predictive Model for Patients with Thrombotic Thrombocytopenic Purpura (TTP) and TTP-Like Syndrome
Lv M, Hu X, Zhu L, Xu H, Chen E, Zhao N, Tong J, Zheng C
Vascular Health and Risk Management 2025, 21:153-165
Published Date: 24 March 2025
Highly Curative Treatment of High-Risk Acute Promyelocytic Leukemia: Induction and Consolidation with ATRA+ATO+anthracyclines and Maintenance with ATRA+RIF
Liu D, Tong J, Chen E, Wang L, Xue L, Zhang X, Zhao N, Hu X, Zheng C
Blood and Lymphatic Cancer: Targets and Therapy 2024, 14:63-69
Published Date: 29 July 2024
Can COVID-19 Increase Platelet in Adult Immune Thrombocytopenia During the TPO-RA Administration? A Real-World Observational Study
Wang X, Zhu Y, Liu D, Zhu L, Tong J, Zheng C
Journal of Blood Medicine 2024, 15:217-225
Published Date: 7 May 2024
Selinexor Synergistically Promotes the Antileukemia Activity of Venetoclax in Acute Myeloid Leukemia by Inhibiting Glycolytic Function and Downregulating the Expression of DNA Replication Genes
Jiang J, Wang Y, Liu D, Wang X, Zhu Y, Tong J, Chen E, Xue L, Zhao N, Liang T, Zheng C
ImmunoTargets and Therapy 2023, 12:135-147
Published Date: 23 November 2023
Standard-Intensity Induction and Intermediate/High-Dose Cytarabine Consolidation Can Improve Survival for Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia: A Retrospective Cohort Study
Wang L, Zhao N, Zhou L, Tong J, Xue L, Zhang L, Han Y, Wang X, Geng L, Tang B, Liu H, Zhu W, Cai X, Liu X, Zhu X, Sun Z, Zheng C
Clinical Interventions in Aging 2022, 17:55-64
Published Date: 20 January 2022
Efficacy of Venetoclax Combined with Decitabine-Based Treatment for Heavily Pre-Treated Relapsed or Refractory AML Patients in a Real-World Setting
Tong J, Zhao N, Hu X, Yao W, Cheng Y, Zhou L, Liu H, Geng L, Sun Z, Zheng C
Cancer Management and Research 2021, 13:5613-5621
Published Date: 12 July 2021
Protective Effects of Cytomegalovirus DNA Copies ≧1000/mL for AML Patients in Complete Remission After Single Cord Blood Transplantation
Dong MY, Tang BL, Zhu XY, Cheng SQ, Fang XC, Tong J, Wan X, Zheng CC, Liu HL, Sun ZM
Infection and Drug Resistance 2020, 13:373-383
Published Date: 7 February 2020